Skip to main content
Caplight Logo









Holobiome

Holobiome

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://holobiome.org/

Last Round

Seed Round

Jul 22, 2026

Total Funding Raised

$11.99M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Holobiome is a biotechnology company that discovers and develops first-in-class therapies from the human microbiome to treat nervous system disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

microbiome therapeuticsgut-brain axislive biotherapeuticsmicrobiome discovery platformprobioticsmental health therapeuticspsychobioticsmicrobial strain bankdrug discovery platformgut healthtarget-directed screeningmulti-omicsAI biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Holobiome Comparables

Compare Holobiome with similar companies based on industry and business-model similarity.

Holobiome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bloom Science
85%
Verb Biotics
81%
Polybiomics
78%

Holobiome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 22, 2026
SeedOct 9, 2024
GrantOct 27, 2021
GrantSep 24, 2021
GrantSep 23, 2020
Seed
Apr 10, 2019

Key People

Founding team and executive leadership

Philip Strandwitz

Co-founder and CEO

Founding Team

Holobiome Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 68% MoM.

  • Jul 22, 2026

    $10M raised in Seed Round.

Holobiome Filings

Explore SEC and related filing metadata, where available.

Holobiome filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Holobiome's valuation, stock price, and market status.

Is Holobiome a public or private company?

Holobiome is a private company.

What is the current stock price of Holobiome?

Holobiome is a private company with no public stock price. No recent secondary market data is available.

How much is Holobiome worth (valuation)?

Valuation information for Holobiome is not publicly available.

Can I buy Holobiome stock?

Holobiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Holobiome's last funding round?

Holobiome's most recent funding round was Seed on October 9, 2024.

Who are the main investors in Holobiome?

Key investors in Holobiome include iSelect Fund.

Will Holobiome IPO soon?

No public IPO plans have been announced for Holobiome.

How can I track Holobiome secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Holobiome's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range16
Year Founded2015
Last FundingJul 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?